Business Description
Toleranzia AB
ISIN : SE0007438577
Compare
Compare
Traded in other countries / regions
TOL.Sweden0EH.Germany IPO Date
2015-12-16Description
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 38.25 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.11 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 40.9 | |||||
| 3-Year EPS without NRI Growth Rate | 32.9 | |||||
| 3-Year FCF Growth Rate | 8.8 | |||||
| 3-Year Book Growth Rate | -8.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.78 | |||||
| 9-Day RSI | 59.69 | |||||
| 14-Day RSI | 56.27 | |||||
| 6-1 Month Momentum % | 18.18 | |||||
| 12-1 Month Momentum % | -52.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.53 | |||||
| Quick Ratio | 4.53 | |||||
| Cash Ratio | 4.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -65 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -6.04 | |||||
| ROA % | -5.75 | |||||
| ROIC % | -7.58 | |||||
| ROC (Joel Greenblatt) % | -10006.67 | |||||
| ROCE % | -5.92 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.66 | |||||
| Price-to-Tangible-Book | 4.06 | |||||
| EV-to-EBIT | -9.45 | |||||
| EV-to-Forward-EBIT | 0.99 | |||||
| EV-to-EBITDA | -9.48 | |||||
| EV-to-Forward-Revenue | 0.47 | |||||
| EV-to-FCF | -1.19 | |||||
| Price-to-Net-Current-Asset-Value | 4.06 | |||||
| Price-to-Net-Cash | 4.4 | |||||
| Earnings Yield (Greenblatt) % | -10.57 | |||||
| FCF Yield % | -54.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Toleranzia AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.069 | ||
| Beta | 0 | ||
| Volatility % | 78.77 | ||
| 14-Day RSI | 56.27 | ||
| 14-Day ATR (kr) | 0.046951 | ||
| 20-Day SMA (kr) | 0.5075 | ||
| 12-1 Month Momentum % | -52.7 | ||
| 52-Week Range (kr) | 0.345 - 1 | ||
| Shares Outstanding (Mil) | 197.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Toleranzia AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Toleranzia AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Toleranzia AB Frequently Asked Questions
What is Toleranzia AB(OSTO:TOL)'s stock price today?
The current price of OSTO:TOL is kr0.53. The 52 week high of OSTO:TOL is kr1.00 and 52 week low is kr0.35.
When is next earnings date of Toleranzia AB(OSTO:TOL)?
The next earnings date of Toleranzia AB(OSTO:TOL) is 2024-05-20.
Does Toleranzia AB(OSTO:TOL) pay dividends? If so, how much?
Toleranzia AB(OSTO:TOL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers